Hyundai Bioscience

048410.KQ

11.26 USD

1.07

+10.50%

Overview

Last close

11.26 usd

Market cap

1.08B usd

52 week high

13.86 usd

52 week low

3.13 usd

Target price

N/A usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

804.4478

Price/Book Value

13.0886

Enterprise Value

955.93M usd

EV/Revenue

721.3723

EV/EBITDA

-64.6317

Key financials

Revenue TTM

1.33M usd

Gross Profit TTM

54988.53 usd

EBITDA TTM

-10.39M usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

83.26M usd

Net debt

N/A usd

About

Hyundai Bioscience Co., Ltd. operates as a biotechnology company. The company provides Vitabrid C12, a vitamin C product that delivers active vitamin C into the skin. It develops Polytaxel, a drug for pancreatic cancer and solid tumors; and CP-COV03 drug for Covid 19. The company was founded in 2000 and is based in Seoul, South Korea.